ArticleBlood advances2024
Röth A, Broome CM, Barcellini W, et al. Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. Blood Adv. 2023;7(19):5890-5897.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.